Brief: NeuBase Therapeutics Reports Results For The Second Quarter Of Fiscal Year 2022
12/05/2022 22:22
May 12 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS BUSINESS UPDATE AND FINANCIAL
RESULTS FOR THE SECOND QUARTER OF FISCAL YEAR 2022
* Q2 LOSS PER SHARE $0.30
Source text for Eikon: ID:nGNX2B8QX6
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet